Receptors, Thrombopoietin
"Receptors, Thrombopoietin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors that are specific for THROMBOPOIETIN. They signal through interaction with JANUS KINASES such as JANUS KINASE 2.
MeSH Number(s)
D12.776.543.750.705.852.610
D23.050.301.264.035.881
D23.101.100.110.883
Concept/Terms
Receptors, Thrombopoietin- Receptors, Thrombopoietin
- Thrombopoietin Receptors
- MPL Ligand Receptor
- Ligand Receptor, MPL
- Receptor, MPL Ligand
- Thrombopoietin Receptor
- Receptor, Thrombopoietin
- Antigens, CD110
- CD110 Antigens
Below are MeSH descriptors whose meaning is more general than "Receptors, Thrombopoietin".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Thrombopoietin [D12.776.543.750.705.852.610]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, CD [D23.050.301.264.035]
- Receptors, Thrombopoietin [D23.050.301.264.035.881]
- Biological Markers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, CD [D23.101.100.110]
- Receptors, Thrombopoietin [D23.101.100.110.883]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Thrombopoietin".
This graph shows the total number of publications written about "Receptors, Thrombopoietin" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Thrombopoietin" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 4 | 4 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 3 | 3 |
| 1998 | 0 | 4 | 4 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 3 | 4 |
| 2008 | 2 | 1 | 3 |
| 2009 | 1 | 3 | 4 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 2 | 3 |
| 2012 | 1 | 3 | 4 |
| 2013 | 2 | 7 | 9 |
| 2014 | 2 | 3 | 5 |
| 2015 | 3 | 6 | 9 |
| 2016 | 5 | 3 | 8 |
| 2017 | 3 | 3 | 6 |
| 2018 | 5 | 5 | 10 |
| 2019 | 2 | 4 | 6 |
| 2020 | 0 | 1 | 1 |
Below are the most recent publications written about "Receptors, Thrombopoietin" by people in Profiles.
-
Both sides now: losses and gains of mutant CALR. Blood. 2020 01 09; 135(2):82-83.
-
Mutant calreticulin in myeloproliferative neoplasms. Blood. 2019 12 19; 134(25):2242-2248.
-
Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac development. Leukemia. 2020 02; 34(2):510-521.
-
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms. Blood. 2019 07 11; 134(2):199-210.
-
Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants. Blood. 2019 06 20; 133(25):2669-2681.
-
Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2). Hepatology. 2019 10; 70(4):1336-1348.
-
The BRISC deubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination. Blood. 2019 04 04; 133(14):1560-1571.
-
Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study. Am J Hematol. 2019 02; 94(2):200-208.
-
Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim. Ann Hematol. 2019 Mar; 98(3):581-588.
-
Characteristics of myeloproliferative neoplasms in patients exposed to ionizing radiation following the Chernobyl nuclear accident. Am J Hematol. 2019 01; 94(1):62-73.